Logo do repositório
 
Publicação

Predicting transporter effects on the pharmacokinetics of metabolized drugs

dc.contributor.advisorMorais, José Augusto Guimarães, 1942-por
dc.contributor.advisorBenet, Leslie Z.
dc.contributor.advisorRodrigues, Maria da Graça Soveral, 1959-por
dc.contributor.authorEstudante, Maria Margarida André Oliveira, 1974-
dc.date.accessioned2011-10-19T12:58:12Z
dc.date.available2011-10-19T12:58:12Z
dc.date.issued2011
dc.descriptionTese de doutoramento, Farmácia (Biofarmácia e Farmacocinética), Universidade de Lisboa, Faculdade de Farmácia, 2011
dc.description.abstractThere is an ongoing debate among the scientific community regarding the role of uptake and efflux transporters in drug BA and BA predictions from in vitro systems. The studies presented in this thesis were planned to clarify whether a simple categorization of drugs (BDDCS) may allow prediction of the importance of intestinal transporters on the disposition of drugs. The bidirectional transport of the highly S and highly P drugs verapamil and diltiazem (Class 1 drugs) and the highly P and low S drug saquinavir (Class 2 drug) was investigated across Caco-2 and MDR1-overexpressing MDCK (MM) cells. All drugs behaved as P-gp substrates in MM cells, but diltiazem and verapamil Papp was P-gp independent in Caco-2 cells. It was concluded that the superior TEER values of MM cell line leads to increased sensitivity in identifying P-gp substrates, although the Caco-2 cells are more representative of the human intestine. We know of no consistent evidence that P-gp affects verapamil absorption in the intestine, although it proved to be a P-gp substrate in the brain and in certain cellular systems. Therefore we studied the role of P-gp on the absorption of verapamil in the rat intestine in comparison with the Class 2 drug atorvastatin . Both drugs showed to be P-gp substrates in the rat intestine. Transporter-CYp3a4 interplay was evaluated for verapamil but there were no statistically significant differences between Extraction ratios in the absence and presence of GG918. Incubation of verapamil and digoxin was studied in the presence and absence of several uptake transporters inhibitors: tetraethylammonium, quinidine, rifampicin and verapamil, in Caco-2 cells. Initial uptake rates exhibited a linear profile for verapamil and suggested saturation for digoxin. The present results support the BDDCS prediction that transporter effects can be relevant in intestinal absorption of Class 2 drugs but not of Class 1 drugs.en
dc.description.provenanceSubmitted by amelia Janeiro (ajaneiro@reitoria.ul.pt) on 2011-10-19T11:31:54Z No. of bitstreams: 1 ulsd061223_td_Maria_Estudante.pdf: 54584092 bytes, checksum: 62356aea939b912e22821ee18c894f07 (MD5)en
dc.description.provenanceMade available in DSpace on 2011-10-19T12:58:12Z (GMT). No. of bitstreams: 1 ulsd061223_td_Maria_Estudante.pdf: 54584092 bytes, checksum: 62356aea939b912e22821ee18c894f07 (MD5) Previous issue date: 2011en
dc.description.sponsorshipFundação para a Ciência e a Tecnologia (FCT, SFRH/BD/31025/2011)por
dc.identifier.urihttp://hdl.handle.net/10451/4317
dc.language.isoengpor
dc.subjectTeses de doutoramento - 2011por
dc.titlePredicting transporter effects on the pharmacokinetics of metabolized drugspor
dc.typedoctoral thesis
dspace.entity.typePublication
rcaap.rightsopenAccesspor
rcaap.typedoctoralThesispor

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
ulsd061223_td_Maria_Estudante.pdf
Tamanho:
52.06 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição:

Coleções